International post-market observational study

EASEE-LEE

Long-term registry on Epilepsy Evolution in subjects treated with transcranial focal cortex stimulation

Duration of study: 5 years

Course of study:

Inclusion: Subjects meeting EASEE® System indication for use and willing to complete seizure diary.
Implantation: Treatment-related procedure according to standard care.
Follow-up visits as part of routine care (at least once a year).
End of study 5 years after inclusion.

Patient profile & key inclusion criteria:

Patient is at least 18 years old.
There is a clinical diagnosis of pharmacoresistant focal epilepsy.
Treatment failure of two adequately selected seizure suppressants in sufficient dosage.
Study participants with observable distinct seizures that can be counted and documented in seizure diary

Scientific research lead EASEE-LEE

PD Dr. med. Elisabeth Kaufmann

Epilepsy Center, Department of Neurology, LMU Munich

Contact

Do you have further questions about the study design and how you can recruit your patients as study participants?

Please feel free to contact us!

Send an email to Dr. Kaufmann

Study for adolescents aged 12 and over

EASEE4YOU

The EASEE4YOU study evaluates transcranial focal cortex stimulation for medically refractory epilepsies in adolescents. Read more about the study design. Do your patients fit the patient profile?

Learn more about EASEE4YOU